Find:
Home > Continuing Medical Education
CME Hyperlipidemia April 2016 Evaluation

3.1 Define clinical atherosclerotic cardiovascular disease (ASCVD) and ASCVD risk factors
3.2 Identify the advantages and disadvantages of LLT
3.3 Determine statin therapy initiation, intensity, and treatment goals based on the presence of ASCVD or ASCVD risk factors
3.4 Discuss non-statin agents as second-line options for the treatment of hypercholesterolemia
4.1 The content seemed current
4.2 The course content was relevant to my practice
4.3 Knowledge gained (How well did you improve your knowledge of the subject?)
5.1 The presenter demonstrated topic mastery
5.2 Pace (How well did the speaker move through the subject?)
6.1 The presenter demonstrated topic mastery
6.2 Pace (How well did the speaker move through the subject?)
7.1 The instructional material was well organized
7.2 The material sufficiently covered the topic
7.3 The material is likely to be useful as future reference
8.1 The instructions were clear on how to navigate the program
8.2 The connectivity to the program was trouble-free
8.3 The video was of good quality
8.4 The audio was clear
8.5 If offered, how likely I plan to attend webinar activities in the future
8.6 The pre/post test assessment increased my knowledge of the subject matter
If you disagree, please be specific in your explanation: